Wu Xiaobin

President and COO

Wu Xiaobin has filed 8 SEC Form 4 filings (22 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Aug 27, 2026.

On the most recent filing, Wu Xiaobin is listed as President and COO at BeOne Medicines Ltd. Inside the rolling window, Wu Xiaobin reported no open-market purchases and 8 open-market sales totaling $8.8M in ONC. The largest disclosed transaction in the window is a sale of 10,000 ONC shares on Nov 12, 2025, worth $3.6M.

Companies traded

Other insiders at ONC

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$8.8M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ONCSale$106KAug 27SEC ↗
ONCSale$357KJun 25SEC ↗
ONCSale$362KJun 18SEC ↗
ONCSale$164KJun 15SEC ↗
ONCSale$400KJun 10SEC ↗
ONCSale$1.5MNov 19SEC ↗
ONCSale$3.6MNov 14SEC ↗
ONCSale$2.3MNov 14SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Wu Xiaobin made?

Wu Xiaobin has filed 8 SEC Form 4 filings (22 transaction rows) across 1 company since 2025.

Which companies does Wu Xiaobin trade?

Wu Xiaobin has filed SEC Form 4 disclosures for 1 company, including ONC.

When was Wu Xiaobin's most recent SEC Form 4 filing?

Wu Xiaobin's most recent SEC Form 4 filing on Tracefour is dated Aug 27, 2026.

What is Wu Xiaobin's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Wu Xiaobin is listed as President and COO.

What is Wu Xiaobin's total buy and sell value in the current window?

Inside the rolling retention window, Wu Xiaobin bought $0 and sold $8.8M based on SEC Form 4 filings.

What was Wu Xiaobin's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 10,000 ONC shares on 2025-11-12, worth $3.6M, per SEC Form 4 filings.